Substance / Medication

Trovafloxacin

Overview

Active Ingredient
trovafloxacin
RxNorm CUI
115552

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

13 trials linked to this intervention

13
Total Trials
3
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Determination of trovafloxacin and marbofloxacin in sheep plasma samples by HPLC using UV detection.
Mahmood Adnan H, Medley Gregory A, Grice Jeffrey E et al. · J Pharm Biomed Anal · 2012
PMID: 22305082Observational
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins Helen S, Spencer Stephen, Brew Simon D et al. · Int J Antimicrob Agents · 2010
PMID: 20022474Observational
Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells.
Liguori Michael J, Blomme Eric A G, Waring Jeffrey F · Drug Metab Dispos · 2008
PMID: 17967932Observational
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Barequet Irina S, Denton Paul, Osterhout Gerard J et al. · Arch Ophthalmol · 2004
PMID: 14718297Observational
Determination of the antibacterial trovafloxacin by differential-pulse adsorptive stripping voltammetry.
Vílchez José Luis, Taoufiki Jalila, Araujo Lilia et al. · J Pharm Biomed Anal · 2003
PMID: 12615233Observational
The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat.
Nathan Barnett R, Scheld W Michael · Life Sci · 2003
PMID: 12888116Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Trovafloxacin (substance)
SNOMED CT
96092008
UMLS CUI
C0379881
RxNorm CUI
115552

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

13
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
13
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Trovafloxacin — Conditions, Biomarkers & Specialists | Healos | Ltrl